IMMUNOSUPPRESSION IN BURKITT'S LYMPHOMA. I. CUTANEOUS REACTIVITY TO RECALL ANTIGENS: ALTERATIONS INDUCED BY A TUMOUR BURDEN AND BY BCG ADMINISTRATION = IMMUNOSUPPRESSION DANS LE LYMPHOME DE BURKITT. I.REACTIVITE CUTANEE AUX ANTIGENES DE RAPPEL: ALTERATIONS PROVOQUEES PAR UNE CHARGE TUMORALE ET PAR L'ADMINISTRATION DE BCGMAGRATH IT.1974; INTERNATION. J. CANCER; SWITZ.; DA. 1974; VOL. 13; NO 6; PP. 839-849; ABS. FR.; BIBL. 1P.Article

IMMUNOSUPPRESSION IN BURKITT'S LYMPHOMA. II. PERIPHERAL BLOOD LYMPHOCYTE POPULATIONS RELATED TO CLINICAL STATUS.MAGRATH IT; SIMON RM.1976; INTERNATION. J. CANCER; SWITZ.; DA. 1976; VOL. 18; NO 4; PP. 399-408; ABS. FR.; BIBL. 23 REF.Article

SKIN ULCERATION CAUSED BY SALMONELLA DUBLINCARSWELL W; MAGRATH IT.1973; BRIT. MED. J.; G.B.; DA. 1973; NO 5849; PP. 331-332; BIBL. 7REF.Serial Issue

TUMOR LYSIS PANCREATITISSPIEGEL RJ; MAGRATH IT.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 7; NO 2; PP. 169-172; BIBL. 7 REF.Article

DYSPHAGIA AS AN UNUSUAL MANIFESTATION OF BURKITT'S LYMPHOMASARIBAN E; MAGRATH IT.1982; AM. J. DIS. CHILD. (1960); ISSN 0002-922X; USA; DA. 1982; VOL. 136; NO 2; PP. 171-172; BIBL. 15 REF.Article

ROLE OF CYTOPLASMIC LIPIDS IN ALTERING DIPHENYLHEXATRIENE FLUORESCENCE POLARIZATION IN MALIGNANT CELLSSPIEGEL RJ; MAGRATH IT; SHUTTA JA et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 2; PP. 452-458; BIBL. 53 REF.Article

CURE OF BURKITT'S LYMPHOMA: TEN-YEAR FOLLOW-UP OF 157 UGANDAN PATIENTSZIEGLER JL; MAGRATH IT; OLWENY LM et al.1979; LANCET; GBR; DA. 1979; NO 8149; PP. 936-938; BIBL. 6 REF.Article

BURKITT CELL LEUKEMIA WITHOUT ABNORMALITIES OF CHROMOSOMES NO8 AND 14DOUGLASS EC; MAGRATH IT; TEREBELO H et al.1982; CANCER GENET. CYTOGENET.; ISSN 0165-4608; NLD; DA. 1982; VOL. 5; NO 2; PP. 181-185; BIBL. 8 REF.Article

CHARACTERIZATION OF THE EPSTEIN-BARR VIRUS ISOLATED FROM A CELL LINE DERIVED FROM A PATIENT WITH AMERICAN BURKITT'S LYMPHOMAPIZZO PA; MAGRATH IT; JAY G et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 8; PP. 3161-3164; BIBL. 28 REF.Article

SERIAL CYTOGENETIC STUDIES OF NONENDEMIC BURKITT'S LYMPHOMA CELL LINESDOUGLASS EC; MAGRATH IT; LEE EC et al.1980; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1980; VOL. 65; NO 5; PP. 891-895; BIBL. 26 REF.Article

EPSTEIN-BARR VIRUS AND HUMAN MALIGNANCY.ZIEGLER JL; MAGRATH IT; GERBER P et al.1977; ANN. INTERN. MED.; U.S.A.; DA. 1977; VOL. 86; NO 3; PP. 323-336; BIBL. 3 P. 1/2Article

EVALUATION OF CCNU (NSC-79037) USED FOR THE PREVENTION OF CNS INVOLVEMENT IN BURKITT'S LYMPHOMAZIEGLER JL; MAGRATH IT; NKRUMAH FK et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 6; PP. 1155-1156; BIBL. 4 REF.Article

CYTOGENETIC STUDIES IN NON-AFRICAN BURKITT LYMPHOMADOUGLASS EC; MAGRATH IT; LEE EC et al.1980; BLOOD; USA; DA. 1980; VOL. 55; NO 1; PP. 148-155; BIBL. 34 REF.Article

ULTRASOUND EVALUATION OF AMERICAN BURKITT'S LYMPHOMASHAWKER TH; DUNNICK R; HEAD GL et al.1979; J. CLIN. ULTRASOUND; USA; DA. 1979; VOL. 7; NO 4; PP. 279-283; BIBL. 21 REF.Article

HL-A AND BURKITT'S TUMOUR. A STUDY IN UGANDA = HL-A ET TUMEUR DE BURKITT. UNE ETUDE EN OUGANDABODMER JG; BODMER WF; ZIEGLER J et al.1975; TISSUE ANTIGENS; DENM.; DA. 1975; VOL. 5; NO 1; PP. 59-62; BIBL. 8 REF.Article

CHEMOTHERAPY OF CHILDHOOD HODGKIN'S DISEASE IN UGANDAZIEGLER JL; FASS L; BLUMING AZ et al.1972; LANCET; G.B.; DA. 1972; NO 7779; PP. 679-682; BIBL. 19REF.Serial Issue

ACTIVE TRANSPORT OF METHOTREXATE FROM CEREBROSPINAL FLUID IN HUMANSBODE U; MAGRATH IT; BLEYER WA et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 7; PP. 2184-2187; BIBL. 11 REF.Article

B CELL DIFFERENTIATION AND IMMUNOREGULATORY T CELL FUNCTION IN HUMAN CORD BLOOD LYMPHOCYTESTOSATO G; MAGRATH IT; KOSKI IR et al.1980; J. CLIN. INVEST.; USA; DA. 1980; VOL. 66; NO 2; PP. 383-388; BIBL. 25 REF.Article

INTRACEREBRAL BURKITT'S LYMPHOMA. PATHOLOGY, CLINICAL FEATURES AND TREATMENT = LYMPHOME DE BURKITT INTRACEREBRAL. PATHOLOGIE ASPECTS CLINIQUES ET TRAITEMENTMAGRATH IT; MUGERWA J; BAILEY I et al.1974; QUART. J. MED.; G.B.; DA. 1974; VOL. 43; NO 172; PP. 489-508; BIBL. 22REF.Article

LONG-TERM EXPERIENCE WITH BURKITT'S LYMPHOMA IN UGANDAOLWENY CLM; KATONGOLE MBIDDE E; OTIM D et al.1980; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1980; VOL. 26; NO 3; PP. 261-266; BIBL. 14 REF.Article

CORRESPONDENCE RE: R.J. SPIEGEL, I.T. MAGRATH, AND J.A. SHUTTA. ROLE OF CYTOPLASMIC LIPIDS IN ALTERING DIPHENYLHEXATRIENE FLUORESCENCE POLARIZATION IN MALIGNANT CELLS. CANCER RES., 41: 452-458, 1981: ON THE LIPID FLUIDITY OF MALIGNANT LYMPHOID CELL MEMBRANESVAN BLITTERSWIJK; VAN HOEVEN RP; EMMELOT P et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 9; PART. 1; PP. 3670-3671; BIBL. 17 REF.Article

CT OF AMERICAN BURKITT LYMPHOMAKRUDY AG; DUNNICK NR; MAGRATH IT et al.1981; AM. J. ROENTGENOL.; ISSN 0092-5381; USA; DA. 1981; VOL. 136; NO 4; PP. 747-754; BIBL. 29 REF.Article

COMBINED MODALITY TREATMENT OF BURKITT'S LYMPHOMAZIEGLER JL; MAGRATH IT; DEISSEROTH AB et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 12; PP. 2031-2034; BIBL. 4 REF.Article

LACTATE DEHYDROGENASE ISOENZYMES IN NORMAL AND MALIGNANT HUMAN LYMPHOID CELLSBLATT J; SPIEGEL RJ; PAPADOPOULOS NM et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 60; NO 2; PP. 491-494; BIBL. 15 REF.Article

The pathogenesis of Burkitt's lymphomaMAGRATH, I.Advances in cancer research. 1990, Vol 55, pp 133-270, issn 0065-230X, 138 p.Article